Skip to content

Community-acquired Pneumonia

Community-acquired pneumonia (CAP) is a lung infection picked up in everyday settings rather than in a healthcare facility. It ranges from a mild illness managed at home to a serious condition requiring hospital care. Bacterial causes are common, with Streptococcus pneumoniae the most frequently identified pathogen.

Zithromax

Azithromycin

100 · 250 · 500 · 1000mg

Azithromycin film-coated tablets from 100mg to 1000mg, used for bacterial pneumonia and skin infection. A macrolide that halts protein synthesis.

From$0.43/ tabletView

Avelox

Moxifloxacin

400mg

Moxifloxacin 400mg film-coated tablets, used for bacterial pneumonia, acute sinusitis and complicated skin and soft tissue infection. A fluoroquinolone.

From$6.63/ tabletView

Omnicef

Cefdinir

300mg

Cefdinir 300mg tablets, used for community-acquired pneumonia, acute otitis media, pharyngitis and exacerbations of chronic bronchitis. A cephalosporin.

From$3.35/ tabletView

Ceftin

Cefuroxime

250 · 500mg

Cefuroxime 250mg and 500mg film-coated tablets, used for pharyngitis, otitis media, urinary tract infection and pneumonia. A second-generation cephalosporin.

From$3.49/ tabletView

Key points

  • Streptococcus pneumoniae is the most frequently identified culprit, though the infection can also have a viral origin.
  • Typical signs include fever, a productive cough and chest pain that intensifies with breathing, alongside fatigue in worse cases.
  • Antibiotics such as cefdinir treat mild-to-moderate cases in people well enough to be managed at home rather than in hospital.

Recognising and treating CAP

Typical signs include a productive cough, fever, chills, and chest pain that worsens on breathing. Shortness of breath and fatigue follow quickly in more severe cases. A doctor will usually confirm the diagnosis with a chest X-ray and, where needed, a sputum culture to identify the organism involved.

When a bacterial pathogen is confirmed or strongly suspected, antibiotics are the cornerstone of treatment. Oral agents such as cefdinir are used for mild-to-moderate CAP in adults and children who can be managed outside hospital. The choice and duration depend on local resistance patterns and individual patient factors.

Seek medical attention promptly if breathing becomes laboured, lips or fingertips turn bluish, or symptoms worsen after 48 hours of treatment.

Further reading